Actavis To Offer $8.4B In Shares To Fund Allergan Takeover
By Zachary Zagger ( February 19, 2015, 1:35 PM EST) -- Actavis PLC said Thursday it plans to sell $8.4 billion in shares in two public offerings to fund its blockbuster acquisition of Allergan Inc. that will vault the Irish drugmaker to a spot among the worlds' top 10 pharmaceutical giants....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.